Mkts

Alaunos Therapeutics, Inc.

NASDAQ: TCRT
$1.60-0.03 (-1.84%)
As of Nov 16, 4:00 PM ET

Key statistics

Day range
1.581.68
52-week range
0.724.50
Today
Open1.59
Previous close1.60
Volume32.04M
Valuation
Market cap6.85M
P/E ratio—
EPS (TTM)-1.82
Income & risk
Dividend / yield—
Beta-1.01
Avg volume5.37M
Discussion

TCRT News

Stories mentioning TCRT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.003.000.000.002.005.000.004.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development427.00362.00469.00185.00347.00(87.00)143.00180.00
Sales General & Admin
Total Operating Expenses1,012910.001,1871,0391,094759.001,1501,170
Operating Income (Loss)(1,012)(907.00)(1,187)(1,039)(1,092)(754.00)(1,150)(1,166)
Interest Income
Interest Expense0.00
Other Expense6.0014.0028.0019.0019.0013.0023.0037.00
Pretax Income
Tax Provision
Net Income (Loss)(1,006)(893.00)(1,159)(1,051)(1,073)(741.00)(1,127)(1,129)
Earnings Per Share (Basic)(0.59)(0.46)(0.55)(0.63)(0.67)(0.46)(0.70)(0.71)
Earnings Per Share (Diluted)(0.59)(0.46)(0.55)(0.63)(0.67)(0.46)(0.70)(0.71)
Weighted Average Shares Outstanding (Basic)1,9481,9482,1831,6761,6011,6011,6011,600
Weighted Average Shares Outstanding (Diluted)1,9481,9482,1831,6761,6011,6011,6011,600

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About TCRT

Alaunos Therapeutics, Inc. (NASDAQ: TCRT) is a stock listed on the Nasdaq Stock Market under the ticker symbol TCRT. It last traded at $1.60 (Nov 16, 2026, 4:00 PM ET), down 1.8% on the day. That gives Alaunos Therapeutics a market capitalisation of $6.9M.

Over the past 52 weeks TCRT has traded between $0.7200 and $4.50.

Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $1.0M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$0-$1.0M—
Dec 31, 2025$3.0K-$893.0K-29766.7%
Sep 30, 2025$0-$1.2M—
Jun 30, 2025$0-$1.1M—

From Alaunos Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…